Kent Council Discusses Proposal for Medical Marijuana Dispensary

Aug.16.2022
Kent Council Discusses Proposal for Medical Marijuana Dispensary
The Kent planning committee is discussing a proposal for a medical marijuana dispensary on 331 E. Main St.

The Kent Planning Committee will discuss a proposal to establish a medical marijuana dispensary in the city once again.


The committee will convene at 7 pm on Tuesday evening to discuss a proposed pharmacy at 331 E. Main St in Kent County. The meeting will be held in the basement of the Kent Fire Department located at 320 S. DePeyster St.


The current company, Slightly Toasted, submitted a request for site planning and conditional zoning to the city's planning commission in January.


However, after considering input from neighbors and determining that additional details were needed in the on-site plan before voting, the expert panel did not vote.


The owner of Slightly Toasted has stated that if the pharmacy receives approval from the city government and obtains a permit from the state of Ohio, the e-cigarette store will relocate.


However, neighbors of the proposed medical marijuana dispensary are expressing concerns about its proximity to residential areas, the entrance of Kent State University, fraternity houses, and the municipal court.


Statement:


This article is compiled from third-party information sources and is intended solely for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry-related communication and research purposes.


Due to limitations in the level of translation, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions.


The ownership of the copyright for the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK busts major illegal e-cigarette case involving 120,000 units; ringleader gets one year in prison
UK busts major illegal e-cigarette case involving 120,000 units; ringleader gets one year in prison
In 2024, UK trading standards uncovered a nationwide illegal e-cigarette supply operation. Business owner Amandeep Kukraja supplied nearly 120,000 illegal products nationwide and received a 12-month probation sentence plus forfeiture of over £300,000 in criminal proceeds.
Sep.12 by 2FIRSTS.ai
Illegal Market Surges After Kazakhstan Bans E-Cigarettes; Telegram Becomes the Main Trading Channel
Illegal Market Surges After Kazakhstan Bans E-Cigarettes; Telegram Becomes the Main Trading Channel
Since Kazakhstan banned e-cigarette sales in June 2024, transactions have gone underground, shifting to Telegram and some e-commerce platforms and making enforcement harder; related research indicates the ban has not significantly reduced demand.
Oct.20 by 2FIRSTS.ai
InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation
InterTabac 2025 Highlights Europe’s Vaping Dilemma: Tighter Regulation, Constrained Innovation
According to 2Firsts’ on-site observations, the vaping halls at InterTabac 2025 have visibly cooled: fewer exhibitors, a weaker presence from major brands, and scarce stage activations; new product momentum is weak and homogenization has intensified. Tightening regulation and policy uncertainty are squeezing innovation, pushing companies to replicate proven models—overall, a “cautious showcase.”
Sep.19 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Gallery | InterTabac 2025 Kicks Off with Exclusive Look at ELFBAR, SKE, RELX, VAPORESSO and More
Gallery | InterTabac 2025 Kicks Off with Exclusive Look at ELFBAR, SKE, RELX, VAPORESSO and More
The InterTabac 2025 exhibition in Dortmund, Germany, is officially underway. 2Firsts is on the ground, providing an exclusive photo gallery that highlights the booth designs of various exhibitors while offering in-depth analysis of show dynamics, industry trends, and brand highlights.
Sep.18
Product | Magnetic-attach design + mini display: FASTA’s new product goes on sale in the U.S., priced around $16
Product | Magnetic-attach design + mini display: FASTA’s new product goes on sale in the U.S., priced around $16
FASTA’s 40K Kit hits U.S. retailers: magnetic prefilled pods + reusable battery, mini display, two power levels; rated 20 mL/40,000 puffs/50 mg; some listings at $15.99.
Oct.15 by 2FIRSTS.ai